2-amino-5-phosphonovalerate has been researched along with captopril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Borkowski, J; Ducret, T; Gentsch, C; Haeusler, A; Hengerer, B; Lederer, R; Mondadori, C; Racine, A | 1 |
2 other study(ies) available for 2-amino-5-phosphonovalerate and captopril
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Pretreatment with aldosterone or corticosterone blocks the memory-enhancing effects of nimodipine, captopril, CGP 37,849, and strychnine in mice.
Topics: 2-Amino-5-phosphonovalerate; Aldosterone; Animals; Avoidance Learning; Captopril; Corticosterone; Darkness; Male; Memory; Mice; Nimodipine; Receptors, N-Methyl-D-Aspartate; Strychnine | 1992 |